Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +7.32% | -13.51% | +74.26% |
04-29 | Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children | MT |
04-29 | Transcript : Aquestive Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.26% | 299M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Aquestive Therapeutics : Wedbush Adjusts Price Target on Aquestive Therapeutics to $28 From $30, Keeps Outperform Rating